4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-004345
See Remarks sold 10,000 shares at $14.03 ($140,300)
- See Remarks acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan See Remarks | 2023-01-18 | Option exercise | +10,000 | $0.73 | $7,300 | 77,600 | D |
| McNeill Jonathan See Remarks | 2023-01-18 | Sale | −10,000 | $14.03 | $140,300 | 67,600 | D |
| Derivatives | |||||||
| McNeill Jonathan See Remarks | 2023-01-18 | Option exercise · Stock Option (right to buy) | −10,000 | 68,528 | D | ||
| Open-market sales · 10,000 sh · avg $14.03 · $140,300 | |||||||
Loading xslF345X03/doc4.xml…